SenzaGen AB
Research SenzaGen AB (SENZA) on Bullrun: market cap SEK 174.89M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSENZA
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencySEK
- Market capSEK 174.89M
- Financial periodQ4 2025
- RevenueSEK 15.58M
- Net income-SEK 4.46M
- Free cash flow-SEK 730.00K
- Gross margin55.3%
Valuation Snapshot
latest market cap is SEK 174.89M.
About SenzaGen AB
SenzaGen AB provides non-animal tests for assessing allergenicity. The company offers GARD skin OECD 442E, GARD skin dose-response, GARD skin medical device; and GARD air, a respiratory sensitization assessment. It also provides biological evaluation, in vitro biocompatibility testing, cytotoxicity, irritation, and skin sensitization medical device services; advisory services for medical devices; and substance based medical devices.
Frequently asked questions
What is SenzaGen AB's market cap?
SenzaGen AB's market capitalization is SEK 174.89M.
What does SenzaGen AB do?
SenzaGen AB provides non-animal tests for assessing allergenicity. The company offers GARD skin OECD 442E, GARD skin dose-response, GARD skin medical device; and GARD air, a respiratory sensitization assessment.